FDA Approves Tec-Dara for Relapsed Multiple Myeloma

Sat, 14 Mar 2026 15:49:42 +0000
Healthcare

The FDA has approved Tec-Dara (teclistamab and daratumumab hyaluronidase-fihj) for relapsed or refractory multiple myeloma. This approval was granted under the Commissioner's National Priority Voucher (CNPV) pilot program, marking a significant acceleration in the review process.